Related Experiment Videos
Equine recurrent uveitis: new methods of management
Brian C Gilger1, Tammy Miller Michau
1Department of Ophthalmology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA. Brian_Gilger@ncsu.edu
The Veterinary Clinics of North America. Equine Practice
|July 24, 2004
Summary
Equine recurrent uveitis (ERU) is a common cause of equine blindness. Recent advances offer new medical and surgical treatments beyond traditional symptomatic therapies for horses with ERU.
Area of Science:
- Veterinary Ophthalmology
- Equine Medicine
Background:
- Equine recurrent uveitis (ERU) is a leading cause of blindness in horses.
- Traditional treatments for ERU primarily involve symptomatic therapy with steroidal and nonsteroidal medications.
- Limited understanding of ERU pathogenesis historically restricted therapeutic options.
Purpose of the Study:
- To review the clinical features and causes of equine recurrent uveitis (ERU).
- To highlight recent advancements in medical and surgical management strategies for ERU.
- To provide an overview of current and emerging treatment options for horses affected by ERU.
Main Methods:
- Literature review of recent studies on equine recurrent uveitis (ERU).
- Analysis of clinical presentations and etiological factors associated with ERU.
- Evaluation of novel therapeutic interventions, including medical and surgical approaches.
Main Results:
- Equine recurrent uveitis (ERU) presents with characteristic clinical signs.
- Understanding the underlying disease processes has paved the way for innovative treatments.
- New medical and surgical therapies are now available for managing ERU.
Conclusions:
- Significant progress has been made in understanding and treating equine recurrent uveitis (ERU).
- New therapeutic options offer improved management for horses suffering from this debilitating condition.
- Further research into ERU pathogenesis may lead to even more effective treatments in the future.